Rudolf Krauser

Stability and cellular studies of [ rac -1,2-bis(4-fluorophenyl)- ethylenediamine][cyclobutane-1,1-dicarboxylato]platinum(II), a novel, highly active carboplatin derivative

Ronald Gust, Beate Schnurr, Rudolf Krauser et al. · Journal of Cancer Research and Clinical Oncology · 1998 · 45 citations · Full text

Medicine, Medicinal Chemistry, Oncology +12

Breast cancer inhibiting diastereomeric diacetato[1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II) derivatives: synthesis and studies on the relationship between reactivity and antitumor activity

Ronald Gust, Rudolf Krauser, Beate Schmid et al. · Inorganica Chimica Acta · 1996 · 16 citations

Medicine, Medicinal Chemistry, Oncology +14

[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]sulfato-platinum(II) — Pharmacokinetic Studies

Günther Bernhardt, Marion Koch, Thilo Spruß et al. · Archiv der Pharmazie · 1999 · 15 citations

Medicine, Oncology, Pharmacology +8

Development of a Parenterally Administrable Hydrosol Preparation of the “Third Generation Platinum Complex” [(±)‐1,2‐Bis(4‐fluorophenyl)ethylenediamine]dichloroplatinum(II). Part 1. Preparation and Studies on the Stability and Antitumor Activity

Ronald Gust, Günther Bernhardt, Thilo Spruß et al. · Archiv der Pharmazie · 1995 · 11 citations

Medicine, Medicinal Chemistry, Pharmacology +14

[1, 2‐Bis(2, 6‐difluoro‐3‐hydroxyphenyl)ethylene‐diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer ‐ Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug‐Target Interaction to the Antitumor Activity

Sabine Schertl, Rolf W. Hartmann, Christine Batzl‐Hartmann et al. · Archiv der Pharmazie · 2004 · 11 citations

Medicine, Medicinal Chemistry, Pharmacology +17